De Yong Wen
Chief Executive Officer chez SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Fortune : 597 223 $ au 31/03/2024
Postes actifs de De Yong Wen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SINOPHARM GROUP CO. LTD. | Director/Board Member | 01/09/2017 | - |
| CHINA NATIONAL MEDICINES CORPORATION LTD. | Director/Board Member | 09/05/2019 | - |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Director/Board Member | 10/08/2022 | - |
| Chief Executive Officer | 01/06/2022 | - | |
| Corporate Officer/Principal | - | - | |
| President | - | 01/06/2022 | |
| SHANGHAI HENLIUS BIOTECH, INC. | Director/Board Member | 28/07/2022 | - |
| CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD. | Chairman | 10/07/2019 | - |
Sinopharm Industrial Investment Co., Ltd.
 Sinopharm Industrial Investment Co., Ltd. Financial ConglomeratesFinance Sinopharm Industrial Investment Co., Ltd. engages in the provision of industrial investment services. Its business activities include management of pharmaceutical business, asset restructuring and investment advisory services. The company was founded on May 6, 2008 and is headquartered in Shanghai, China. | Director/Board Member | 20/01/2020 | - |
Historique de carrière de De Yong Wen
Anciens postes connus de De Yong Wen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Chongqing Yao Pharmaceutical Co., Ltd.
 Chongqing Yao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Yao Pharmaceutical Co., Ltd. engages in pharmaceutical manufacture, It integrates with research and development, manufacturing, marketing, and sales of medicines. The company was founded on July 21, 1997 and is headquartered in Chongqing, China. | Director/Board Member | - | - |
| C.Q. PHARMACEUTICAL HOLDING CO., LTD. | Director/Board Member | - | - |
Formation de De Yong Wen
| Donghua University | Masters Business Admin |
| West China University of Medical Sciences | Undergraduate Degree |
Statistiques
Internationale
| Chine | 11 |
Opérationnelle
| Director/Board Member | 7 |
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| SINOPHARM GROUP CO. LTD. | Distribution Services |
| CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD. | Health Technology |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Health Technology |
| CHINA NATIONAL MEDICINES CORPORATION LTD. | Health Technology |
| C.Q. PHARMACEUTICAL HOLDING CO., LTD. | Health Technology |
| SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Sinopharm Industrial Investment Co., Ltd.
Sinopharm Industrial Investment Co., Ltd. Financial ConglomeratesFinance Sinopharm Industrial Investment Co., Ltd. engages in the provision of industrial investment services. Its business activities include management of pharmaceutical business, asset restructuring and investment advisory services. The company was founded on May 6, 2008 and is headquartered in Shanghai, China. | Finance |
Chongqing Yao Pharmaceutical Co., Ltd.
Chongqing Yao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Yao Pharmaceutical Co., Ltd. engages in pharmaceutical manufacture, It integrates with research and development, manufacturing, marketing, and sales of medicines. The company was founded on July 21, 1997 and is headquartered in Chongqing, China. | Health Technology |
- Bourse
- Insiders
- De Yong Wen
- Expérience
